Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Bladder Cancer

  Free Subscription


Articles published in Urol Int

Retrieve available abstracts of 37 articles:
HTML format
Text format



Single Articles


    June 2017
  1. NAGAO K, Hara T, Nishijima J, Shimizu K, et al
    The Efficacy of Trimodal Chemoradiotherapy with Cisplatin as a Bladder-Preserving Strategy for the Treatment of Muscle-Invasive Bladder Cancer.
    Urol Int. 2017 Jun 21. doi: 10.1159/000477912.
    PubMed     Text format     Abstract available


  2. POLETAJEW S, Zapala P, Radziszewski P
    Safety and Efficacy of Intravesical Bacillus Calmette-Guerin Immunotherapy in Patients with Non-Muscle-Invasive Bladder Cancer Presenting with Asymptomatic Bacteriuria: A Systematic Review.
    Urol Int. 2017 Jun 10. doi: 10.1159/000477673.
    PubMed     Text format     Abstract available


    April 2017
  3. BALCI M, Tuncel A, Keten T, Guzel O, et al
    Comparison of Monopolar and Bipolar Transurethral Resection of Non-Muscle Invasive Bladder Cancer.
    Urol Int. 2017 Apr 6. doi: 10.1159/000467397.
    PubMed     Text format     Abstract available


    March 2017
  4. NAKAMURA Y, Yoshida S, Tanaka H, Inoue M, et al
    Potential Utility of Diffusion-Weighted Magnetic Resonance Imaging in Diagnosis of Residual Bladder Cancer before Second Transurethral Resection.
    Urol Int. 2017 Mar 1. doi: 10.1159/000456722.
    PubMed     Text format     Abstract available


    February 2017
  5. MOSCHINI M, Shariat SF, Freschi M, Soria F, et al
    Impact of Prostate Involvement on Outcomes in Patients Treated with Radical Cystoprostatectomy for Bladder Cancer.
    Urol Int. 2017 Feb 1. doi: 10.1159/000454736.
    PubMed     Text format     Abstract available


    January 2017
  6. LONG X, Qi L, Zu X, Li Y, et al
    Prevention of Recurrent Bladder Tumors after Nephroureterectomy for Primary Upper Urinary Tract Urothelial Carcinoma: An Individualized Selection Strategy Based on Patient Risk Stratification Is Needed.
    Urol Int. 2017;98:312-319.
    PubMed     Text format     Abstract available


  7. WOLTERS M, Oelke M, Lutze B, Weingart M, et al
    Deep Surgical Site Infections after Open Radical Cystectomy and Urinary Diversion Significantly Increase Hospitalisation Time and Total Treatment Costs.
    Urol Int. 2017;98:268-273.
    PubMed     Text format     Abstract available


    December 2016
  8. BREYER J, Otto W, Wirtz RM, Wullich B, et al
    ERBB2 Expression as Potential Risk-Stratification for Early Cystectomy in Patients with pT1 Bladder Cancer and Concomitant Carcinoma in situ.
    Urol Int. 2016.
    PubMed     Text format     Abstract available


  9. D'ELIA C, Comploj E, Cerruto MA, Trenti E, et al
    90-Day Mortality after Radical Cystectomy for Bladder Cancer: Prognostic Factors in a Multicenter Case Series.
    Urol Int. 2016.
    PubMed     Text format     Abstract available


    September 2016
  10. BURGE F, Kockelbergh R
    Closing the Gender Gap: Can We Improve Bladder Cancer Survival in Women? - A Systematic Review of Diagnosis, Treatment and Outcomes.
    Urol Int. 2016.
    PubMed     Text format     Abstract available


    July 2016
  11. SIKIC D, Wach S, Taubert H, Richterstetter M, et al
    How Octogenarians with Bladder Cancer Are Treated in a Maximum-Care Hospital: The Real-Life Experience.
    Urol Int. 2016.
    PubMed     Text format     Abstract available


    February 2016
  12. ZAKARIA AS, Santos F, Kassouf W, Tanguay S, et al
    Survival after Radical Cystectomy for Bladder Cancer in Relation to Prior Non-Muscle Invasive Disease in Quebec.
    Urol Int. 2016.
    PubMed     Text format     Abstract available


  13. FAHMY O, Scharpf M, Schubert T, Feyerabend S, et al
    Ten Years of Complete Remission of Pulmonary Metastasis after Post-Cystectomy Palliative Cisplatin-Gemcitabine Chemotherapy with Gefitinib for Muscle Invasive Bladder Cancer: A Case Report.
    Urol Int. 2016.
    PubMed     Text format     Abstract available


    January 2016
  14. NOVOTNY V, Froehner M, Ollig J, Koch R, et al
    Impact of Adjuvant Intravesical Bacillus Calmette-Guerin Treatment on Patients with High-Grade T1 Bladder Cancer.
    Urol Int. 2016.
    PubMed     Text format     Abstract available


  15. VILASECA A, Huguet J, Perez M, Camacho D, et al
    The Role of Surgery in Local Recurrences after Radical Cystectomy for Bladder Cancer.
    Urol Int. 2016.
    PubMed     Text format     Abstract available


  16. GAKIS G, Rink M, Fritsche HM, Graefen M, et al
    Prognostic Significance of Incidental Prostate Cancer at Radical Cystoprostatectomy for Bladder Cancer.
    Urol Int. 2016.
    PubMed     Text format     Abstract available


  17. CHEN Y, Yang Y, Liu L, Wang S, et al
    Tumor Suppressor in Lung Cancer-1 Is a Prognostic Predictor for the Recurrence and Progression of Non-Muscle-Invasive Bladder Cancer.
    Urol Int. 2016;96:142-7.
    PubMed     Text format     Abstract available


  18. SOORIAKUMARAN P, Chiocchia V, Dutton S, Pai A, et al
    Predictive Factors for Time to Progression after Hyperthermic Mitomycin C Treatment for High-Risk Non-Muscle Invasive Urothelial Carcinoma of the Bladder: An Observational Cohort Study of 97 Patients.
    Urol Int. 2016;96:83-90.
    PubMed     Text format     Abstract available


  19. SERRETTA V, Scalici Gesolfo C, Alonge V, Cicero G, et al
    Does the Compliance to Intravesical BCG Differ between Common Clinical Practice and International Multicentric Trials?
    Urol Int. 2016;96:20-4.
    PubMed     Text format     Abstract available


  20. MARTINI T, Aziz A, Roghmann F, Rink M, et al
    Prediction of Locally Advanced Urothelial Carcinoma of the Bladder Using Clinical Parameters before Radical Cystectomy--A Prospective Multicenter Study.
    Urol Int. 2016;96:57-64.
    PubMed     Text format     Abstract available


  21. MILLER K, Morant R, Stenzl A, Zuna I, et al
    A Phase II Study of the Central European Society of Anticancer-Drug Research (CESAR) Group: Results of an Open-Label Study of Gemcitabine plus Cisplatin with or without Concomitant or Sequential Gefitinib in Patients with Advanced or Metastatic Transi
    Urol Int. 2016;96:5-13.
    PubMed     Text format     Abstract available


  22. TANAKA H, Yoshida S, Komai Y, Sakai Y, et al
    Clinical Value of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Upper Tract Urothelial Carcinoma: Impact on Detection of Metastases and Patient Management.
    Urol Int. 2016;96:65-72.
    PubMed     Text format     Abstract available


  23. GAKIS G, Efstathiou JA, Daneshmand S, Keegan KA, et al
    Oncological Outcomes of Patients with Concomitant Bladder and Urethral Carcinoma.
    Urol Int. 2016;97:134-41.
    PubMed     Text format     Abstract available


  24. D''AGOSTINO D, Racioppi M, Pugliese D, Ragonese M, et al
    Postoperative Quality of Life in Patients with Ileal Neobladder at Short-, Intermediate- and Long-Term Follow-Up.
    Urol Int. 2016;97:54-60.
    PubMed     Text format     Abstract available


    November 2015
  25. HOFBAUER SL, Shariat SF, Chade DC, Sarkis AS, et al
    The Moreau Strain of Bacillus Calmette-Guerin (BCG) for High-Risk Non-Muscle Invasive Bladder Cancer: An Alternative during Worldwide BCG Shortage?
    Urol Int. 2015.
    PubMed     Text format     Abstract available


    October 2015
  26. HORN T, Zahel T, Adt N, Schmid SC, et al
    Evaluation of Computed Tomography for Lymph Node Staging in Bladder Cancer Prior to Radical Cystectomy.
    Urol Int. 2015.
    PubMed     Text format     Abstract available


    September 2015
  27. BRISUDA A, Pazourkova E, Soukup V, Horinek A, et al
    Urinary Cell-Free DNA Quantification as Non-Invasive Biomarker in Patients with Bladder Cancer.
    Urol Int. 2015.
    PubMed     Text format     Abstract available


    August 2015
  28. LATZ S, Umbach T, Goltz D, Kristiansen G, et al
    Cytoplasmatic and Nuclear YAP1 and pYAP1 Staining in Urothelial Bladder Cancer.
    Urol Int. 2015.
    PubMed     Text format     Abstract available


    May 2015
  29. HUPE MC, Merseburger AS, Gunter HH, Wustemann M, et al
    Successful Pregnancy and Neobladder Subsequent to Muscle Invasive Bladder Cancer and Fertility Preserving Surgery: Case Report and Review of the Literature.
    Urol Int. 2015.
    PubMed     Text format     Abstract available


    January 2015
  30. AZIZ A, Madersbacher S, Otto W, Mayr R, et al
    Comparative analysis of gender-related differences in symptoms and referral patterns prior to initial diagnosis of urothelial carcinoma of the bladder: a prospective cohort study.
    Urol Int. 2015;94:37-44.
    PubMed     Text format     Abstract available


  31. COMPLOJ E, West J, Mian M, Kluth LA, et al
    Comparison of complications from radical cystectomy between old-old versus oldest-old patients.
    Urol Int. 2015;94:25-30.
    PubMed     Text format     Abstract available


  32. LIU B, Zhang C, Zhang Q, Liu G, et al
    Primary epithelioid hemangioendothelioma of the bladder: case report and review of the literature.
    Urol Int. 2015;94:240-3.
    PubMed     Text format     Abstract available


  33. LEI Y, Tong S, Zu X, Li Y, et al
    Extraperitoneal and transperitoneal laparoscopic partial cystectomy for benign non-urothelial bladder tumors: an initial experience.
    Urol Int. 2015;94:149-55.
    PubMed     Text format     Abstract available


  34. WANG Y, Wang T, Han Y, Wu H, et al
    Reduced ING4 Expression Is Associated with the Malignancy of Human Bladder.
    Urol Int. 2015;94:464-71.
    PubMed     Text format     Abstract available


  35. GARDE H, Ciappara M, Galante I, Fuentes Ferrer M, et al
    Radical cystectomy in octogenarian patients: a difficult decision to take.
    Urol Int. 2015;94:390-3.
    PubMed     Text format     Abstract available


  36. ESWARA JR, Heney NM, Wu CL, McDougal WS, et al
    Long-term outcomes of organ preservation in patients with small cell carcinoma of the bladder.
    Urol Int. 2015;94:401-5.
    PubMed     Text format     Abstract available


  37. BERGER I, Wehrberger C, Ponholzer A, Wolfgang M, et al
    Impact of the use of bowel for urinary diversion on perioperative complications and 90-day mortality in patients aged 75 years or older.
    Urol Int. 2015;94:394-400.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: